Artisan Partners
DNLI icon

Artisan Partners’s Denali Therapeutics DNLI Stock Holding History

Artisan Partners’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.5M Buy
1,224,497
+124,778
+11% +$2.56M 0.05% 209
2026
Q1 		$21.1M Buy
+1,099,719
New +$21.9M 0.03% 279
2025
Q2 		– Sell
-612,438
Closed -$8.33M – 355
2025
Q1 		$8.33M Sell
612,438
-442,085
-42% -$8.47M 0.01% 311
2024
Q4 		$21.5M Sell
1,054,523
-36,495
-3% -$934K 0.03% 298
2024
Q3 		$31.8M Sell
1,091,018
-50,499
-4% -$1.25M 0.05% 264
2024
Q2 		$26.5M Buy
1,141,517
+775,685
+212% +$14.9M 0.04% 271
2024
Q1 		$7.51M Sell
365,832
-18,110
-5% -$340K 0.01% 306
2023
Q4 		$8.24M Sell
383,942
-22,680
-6% -$449K 0.01% 295
2023
Q3 		$8.39M Sell
406,622
-10,161
-2% -$258K 0.01% 283
2023
Q2 		$12.3M Sell
416,783
-6,882
-2% -$194K 0.02% 266
2023
Q1 		$9.76M Sell
423,665
-12,008
-3% -$330K 0.02% 278
2022
Q4 		$12.1M Sell
435,673
-7,428
-2% -$221K 0.02% 273
2022
Q3 		$13.6M Sell
443,101
-7,588
-2% -$247K 0.02% 273
2022
Q2 		$13.3M Sell
450,689
-73,442
-14% -$1.92M 0.02% 271
2022
Q1 		$16.9M Buy
524,131
+2,723
+0.5% +$93.7K 0.02% 291
2021
Q4 		$23.3M Sell
521,408
-29,579
-5% -$1.4M 0.03% 295
2021
Q3 		$27.8M Sell
550,987
-15,858
-3% -$894K 0.03% 281
2021
Q2 		$44.5M Buy
566,845
+979
+0.2% +$60.6K 0.05% 250
2021
Q1 		$32.3M Buy
565,866
+142,513
+34% +$9.54M 0.04% 288
2020
Q4 		$35.5M Buy
+423,353
New +$25.6M 0.04% 280

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners's DNLI Position: Q2 2026 in Review

Artisan Partners increased its Denali Therapeutics (DNLI) stake by 11% in Q2 2026, buying an estimated $2.56M and bringing the position to 1,224,497 shares worth $31.5M. The position accounts for 0.05% of the portfolio, ranked #209.

Artisan Partners first reported a position in DNLI in Q4 2020 and has held it in 20 quarters since. The position peaked at $44.5M in Q2 2021. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Artisan Partners held 1,224,497 shares of Denali Therapeutics worth $31.5M as of Q2 2026.
  • Artisan Partners bought 124,778 Denali Therapeutics shares in Q2 2026, an estimated $2.56M.
  • Denali Therapeutics made up 0.05% of Artisan Partners's portfolio in Q2 2026, its #209 holding.
  • Artisan Partners first reported a position in Denali Therapeutics in Q4 2020 and has held it in 20 quarters since.
  • Artisan Partners's Denali Therapeutics position peaked at $44.5M in Q2 2021.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Artisan Partners's 13F filing for Q2 2026, filed 13 Aug 2026.